These files contain multiple measures and abbreviations after. What changes have been made to the measures?

File 1 Start:
This table contains the measures and brief descriptions that are included in HEDIS MY 2023. For full specifications, visit the NCQA store.
Measure Name

Abbreviation

Measure Description

Weight Assessment and Counseling for Nutrition and
Physical Activity for Children/Adolescents

WCC

The percentage of members 3–17 years of age who had an outpatient visit with a PCP or OB/GYN and who
had evidence of the following during the measurement year.
• BMI percentile documentation*.
• Counseling for nutrition.
• Counseling for physical activity.
* Because BMI norms for youth vary with age and gender, this measure evaluates whether BMI percentile is
assessed rather than an absolute BMI value.

Childhood Immunization Status

CIS

The percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP);
three polio (IPV); one measles, mumps and rubella (MMR); three haemophilus influenza type B (HiB); three
hepatitis B (HepB), one chicken pox (VZV); four pneumococcal conjugate (PCV); one hepatitis A (HepA);
two or three rotavirus (RV); and two influenza (flu) vaccines by their second birthday. The measure
calculates a rate for each vaccine and three combination rates.

Immunizations for Adolescents

IMA

The percentage of adolescents 13 years of age who had one dose of meningococcal vaccine, one tetanus,
diphtheria toxoids and acellular pertussis (Tdap) vaccine, and have completed the human papillomavirus
(HPV) vaccine series by their 13th birthday. The measure calculates a rate for each vaccine and two
combination rates.

Lead Screening in Children

LSC

The percentage of children 2 years of age who had one or more capillary or venous lead blood test for lead
poisoning by their second birthday.

Cervical Cancer Screening

CCS

The percentage of women 21–64 years of age who were screened for cervical cancer using any of the
following criteria:
• Women 21–64 years of age who had cervical cytology performed within the last 3 years.
• Women 30–64 years of age who had cervical high-risk human papillomavirus (hrHPV) testing
performed within the last 5 years.
• Women 30–64 years of age who had cervical cytology/high-risk human papillomavirus (hrHPV)
cotesting within the last 5 years.

Colorectal Cancer Screening

COL

The percentage of members 45–75 years of age who had appropriate screening for colorectal cancer.

Chlamydia Screening in Women

CHL

The percentage of women 16–24